Adeka Corporation
Notice Regarding Dividend of Surplus (Increase in Dividend)
The Company has decided on the total dividend amount of 5,903 million yen with effective date of June 22, 2026, and has increased the dividend per share to 60 yen. This is an increase of 8 yen from the previous year's same period of 52 yen, with a payout ratio of 40.3%.
Key Figures
- Total Dividends: 5,903 million yen (Compared to previous year +586 million yen)
- Dividend per Share: 60 yen (Compared to previous year +8 yen)
- Payout Ratio: 40.3% (Compared to previous year +0.6 percentage points)
AI要約
Dividend Overview
Takeda Pharmaceutical Company Limited has decided on a total dividend of 5,903 million yen for the fiscal year ending March 2026, increasing the dividend per share to 60 yen. This reflects an increase of 8 yen from the previous year's 52 yen, with a payout ratio of 40.3%. The effective date is scheduled for June 22, 2026, demonstrating the company's commitment to returning value to shareholders.
Future Outlook and Impact on Shareholders
The dividend increase is expected to enhance shareholder returns and boost investment appeal. Takeda Pharmaceutical intends to maintain a stable dividend policy going forward and aims to improve shareholder value. The increase in dividends is positioned as part of the company's sound financial condition and growth strategy.
Takeda Pharmaceutical Company Limited
Company overview · Stock price · Financial data · All IR
